Physician profile
Veronica Shi
NPI 1366897464
$838.20
in general payments reported to CMS, 2019-2025
14 companies · $541 in 2025
The $541 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $215 · 2024: $82.57 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $121.92 | 2023 | Sotyktu |
| Sanofi US Services INC. | $117.10 | 2025 | |
| Galderma Laboratories, L.P. | $106.03 | 2025 | Nemluvio |
| Pharmaessentia USA Corporation | $99.74 | 2024-2025 | Besremi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $92.63 | 2023 | Jublia, Siliq, Arazlo |
| Novartis Pharmaceuticals Corporation | $61.46 | 2025 | |
| Sobi, INC | $60.05 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $44.22 | 2024-2025 | Ultomiris |
| Genzyme Corporation | $31.26 | 2025 | |
| Blueprint Medicines Corporation | $25.14 | 2025 | Ayvakit |
| Geron Corporation | $23.99 | 2025 | Rytelo |
| Glaxosmithkline, LLC. | $20.59 | 2025 | Blenrep |
| Beone Medicines USA, INC. | $19.17 | 2025 | Brukinsa |
| Agios Pharmaceuticals, INC. | $14.90 | 2025 | Pyrukynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Shi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.